Can This High-Yield Dividend Stock Keep Beating the S&P 500?
Dividend stocks are potent instruments for building wealth. A staggering 85% of the S 500's total returns since 1960 have emanated from dividend payouts, according to a report by Hartford Funds.
Amgen (NASDAQ: AMGN), a top-tier U.S. biotech firm, has been a coveted dividend stock since it began regular distributions to shareholders in 2011. Highlighting this fact, the company's shares have significantly outperformed the S 500 during this time.
Source Fool.com
Amgen Inc. Stock
€281.80
0.790%
The stock is an absolute favorite of our community with 25 Buy predictions and no Sell predictions.
With a target price of 296 € there is a slightly positive potential of 5.04% for Amgen Inc. compared to the current price of 281.8 €.
